NDC 55111-652 – Bivalirudin
Bivalirudin 250 mg/1 · Injection · Intracavernous
Product NDC55111-652
Product details
- Brand name
- Bivalirudin
- Generic name
- Bivalirudin
- Labeler
- Dr. Reddy's Laboratories Limited
- Dosage form
- Injection
- Route
- Intracavernous
- Marketing category
- ANDA · ANDA201577
- Marketed since
- May 31, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Anti-coagulant; Direct Thrombin Inhibitor
Active ingredients
- Bivalirudin 250 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55111-652-37 | 10 VIAL, SINGLE-DOSE in 1 CARTON (55111-652-37) / 1 INJECTION in 1 VIAL, SINGLE-DOSE (55111-652-07) | May 31, 2017 |
Other Bivalirudin products
- 16729-275 Bivalirudin 250 mg/5mL · Injection, Powder, Lyophilized, For Solution · Accord Healthcare, Inc.
- 83634-400 Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Solution · Avenacy, LLC
- 72572-035 Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Solution · Civica, Inc.
- 55150-210 Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 63323-562 Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Solution · Fresenius Kabi USA, LLC
- 52958-034 Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 70511-142 Bivalirudin 250 mg/1 · Injection, Solution · MAIA Pharmaceuticals, Inc.
- 71288-427 Bivalirudin 250 mg/5mL · Injection, Powder, Lyophilized, For Solution · Meitheal Pharmaceuticals Inc.
- 67457-256 Bivalirudin 250 mg/5mL · Injection, Powder, Lyophilized, For Solution · Mylan Institutional LLC
- 42023-622 Bivalirudin 250 mg/1 · Injection, Solution · Par Health USA, LLC
- 0781-3158 Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Solution · Sandoz Inc
- 70436-025 Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Suspension · Slate Run Pharmaceuticals, LLC